MTOR and fatty liver disease: Mechanistically, we found that H19 promoted hepatic steatosis by up‐regulating and the mTORC1 signalling axis (including active RAPTOR, mTOR, S6K SREBP and suppress LIPIN1) and MLXIPL transcriptional network in hepatocytes (Figure 7D).